Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco
Jihane Belayachi, Majdouline Obtel, Rachid Razıne, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11

Showing 11 citing articles:

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates
Nawal Al Kaabi, Abderrahim Oulhaj, Subhashini Ganesan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Real-World Effectiveness of Four Types of COVID-19 Vaccines
Derar H. Abdel‐Qader, Hasan Abdel-Qader, Jennifer Silverthorne, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 985-985
Open Access | Times Cited: 12
Effectiveness of Vaccination in Preventing COVID-19: A Community Study Comparing Four Vaccines
Zoran Kokić, Predrag Kon, Olgica Djurković-­Djaković
Vaccines (2023) Vol. 11, Iss. 3, pp. 544-544
Open Access | Times Cited: 5
Effectiveness of Sinopharm’s BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave
Jihane Belayachi, Abdelkader Mhayi, Hind Majidi, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 244-244
Open Access | Times Cited: 1
Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao
Xiao Zhan Zhang, Phyllis Hio Hong Wong, Kai Seng Lai, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 933-933
Open Access | Times Cited: 1
Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China
Yaqun Fu, Jingyu Zhao, Wei Xia, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1712-1712
Open Access | Times Cited: 7
The Real-World Effectiveness of Inactivated COVID-19 Vaccines in Zimbabwe During the Omicron Variant Dominance: A Test-Negative Case–Control Study
Tariro Makadzange, Patricia Gundidza, Kimberly Cheryl Chido Konono, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1303-1303
Open Access
Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study
Tingjuan He, Meixia Wang, Hongfei Mi, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 532-532
Open Access | Times Cited: 1
Harnessing Antiviral Peptides as Means for SARS-CoV-2 Control
Khatereh Zarkesh, Mohsen Akbarian, Lobat Tayebi, et al.
COVID (2023) Vol. 3, Iss. 7, pp. 975-986
Open Access | Times Cited: 1
Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico
Germán Áñez, Karen L. Kotloff, Cynthia L. Gay, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top